Variables | Disease-free survival | |||
---|---|---|---|---|
Univariate analyses | p | Multivariate analyses | p | |
Hazara ratios | Hazara ratios | |||
(95%CI) | (95%CI) | |||
Sex | 0.938(0.556–1.583) | 0.811 | ||
Age | 1.003(0.980–1.027) | 0.804 | ||
BMI | 0.986(0.917–1.060) | 0.698 | ||
Smoke | 1.007(0.605–1.676) | 0.978 | ||
pT stage | ||||
pT2 | Ref. | |||
pT3 | 2.017(1.156–3.520) | 0.014 | 1.683(0.906–2.810) | 0.155 |
pT4 | 6.303(3.066–12.956) | < 0.001 | 7.536(3.131–11.235) | < 0.001 |
NLR | 0.365(0.213–0.625) | < 0.001 | 0.282(0.138–0.575) | < 0.001 |
PLR | 1.030(0.624–1.700) | 0.908 | ||
MLR | 0.607(0.371–0.995) | 0.049 | 1.152(0.604–2.196) | 0.668 |
Chemotherapy | 1.597(0.835–3.056) | 0.157 | ||
Adverse events | 0.541(0.315–0.929) | 0.026 | 0.444(0.254–0.776) | 0.004 |